Antiviral chemistry & chemotherapy · 2005 · 59 citations · 63 references
PharmacyChemistryMedicinal ChemistryBioisosterismDrug DesignDrug DiscoveryAntiretroviral TherapyLead Compound DesignLigand BindingLigand-based DesignMolecular DockingProtein-ligand DockingChemical Synthesis Of AnaloguesDocking StudiesDocking-based Drug DesignHeteroaromatic CompoundsHeteroaromatic Ring BioisosterismStructure-based Lead DiscoveryStructure-based Ligand DesignVirtual Screening Validation
HIV-1 integrase (IN) is an attractive and validated target for the development of novel therapeutics against AIDS. Significant efforts have been devoted to the identification of IN inhibitors using various methods. In this context, through virtual screening of the NCI database and structure-based drug design strategies, we identified several pharmacophoric fragments and incorporated them on various aromatic or heteroaromatic rings. In addition, we designed and synthesized a series of 5-aryl(heteroaryl)-isoxazole-3-carboxylic acids as biological isosteric analogues of beta-diketo acid containing inhibitors of HIV-1 IN and their derivatives. Further computational docking studies were performed to investigate the mode of interactions of the most active ligands with the IN active site. Results suggested that some of the tested compounds could be considered as lead compounds and suitable for further optimization.
63
Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw et al. · Journal of Medicinal Chemistry · 1997 · 2K citations · Full text